These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23662445)

  • 1. Refolding of recombinant human interferon alpha-2a from Escherichia coli by urea gradient size exclusion chromatography.
    Gao F; Shi L; Xu LX
    Prikl Biokhim Mikrobiol; 2013; 49(1):17-23. PubMed ID: 23662445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High recovery refolding of rhG-CSF from Escherichia coli, using urea gradient size exclusion chromatography.
    Wang C; Wang L; Geng X
    Biotechnol Prog; 2008; 24(1):209-13. PubMed ID: 18179225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urea-gradient protein refolding in size exclusion chromatography.
    Wang C; Cheng Y
    Curr Pharm Biotechnol; 2010 Apr; 11(3):289-92. PubMed ID: 20210741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the refolding of NTA protein by urea gradient and arginine gradient size-exclusion chromatography.
    Fan X; Xu D; Lu B; Xia J; Wei D
    J Biochem Biophys Methods; 2008 Apr; 70(6):1130-8. PubMed ID: 18241925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urea gradient size-exclusion chromatography enhanced the yield of lysozyme refolding.
    Gu Z; Su Z; Janson JC
    J Chromatogr A; 2001 May; 918(2):311-8. PubMed ID: 11407577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro refolding with simultaneous purification of recombinant human parathyroid hormone (rhPTH 1-34) from Escherichia coli directed by protein folding size exclusion chromatography (PF-SEC): implication of solution additives and their role on aggregates and renaturation.
    Vemula S; Vemula S; Dedaniya A; Ronda SR
    Anal Bioanal Chem; 2016 Jan; 408(1):217-29. PubMed ID: 26472319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refolding and simultaneous purification of recombinant human proinsulin from inclusion bodies on protein-folding liquid-chromatography columns.
    Yuan J; Zhou H; Yang Y; Li W; Wan Y; Wang L
    Biomed Chromatogr; 2015 May; 29(5):777-82. PubMed ID: 25378200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refolding and purification of rhNTA protein by chromatography.
    Fan X; Xu D; Lu B; Xia J; Wei D
    Biomed Chromatogr; 2009 Mar; 23(3):257-66. PubMed ID: 19101913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and refolding of recombinant human interferon-gamma in urea-ammonium chloride solution.
    Petrov S; Nacheva G; Ivanov I
    Protein Expr Purif; 2010 Sep; 73(1):70-3. PubMed ID: 20363329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatographic methods for the isolation of, and refolding of proteins from, Escherichia coli inclusion bodies.
    Gu Z; Weidenhaupt M; Ivanova N; Pavlov M; Xu B; Su ZG; Janson JC
    Protein Expr Purif; 2002 Jun; 25(1):174-9. PubMed ID: 12071713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative investigation on different refolding strategies of recombinant human tissue-type plasminogen activator derivative.
    Liu H; Zhou X; Zhang Y
    Biotechnol Lett; 2006 Apr; 28(7):457-63. PubMed ID: 16614926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and Refolding to Amyloid Fibrils of (His)6-tagged Recombinant Shadoo Protein Expressed as Inclusion Bodies in E. coli.
    Li Q; Richard CA; Moudjou M; Vidic J
    J Vis Exp; 2015 Dec; (106):e53432. PubMed ID: 26709825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of conditions for high-level expression and purification of human recombinant consensus interferon (rh-cIFN) and its characterization.
    Ahmed N; Bashir H; Zafar AU; Khan MA; Tahir S; Khan F; Khan MI; Akram M; Husnain T
    Biotechnol Appl Biochem; 2015; 62(5):699-708. PubMed ID: 25402716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renaturation of Escherichia coli-derived recombinant human macrophage colony-stimulating factor.
    Tran-Moseman A; Schauer N; De Bernardez Clark E
    Protein Expr Purif; 1999 Jun; 16(1):181-9. PubMed ID: 10336876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-column refolding of corticotropin-releasing factor receptor 1 extracellular domain by size exclusion chromatography.
    Ersoy M; Matic S; Schmidt SR
    Biomed Chromatogr; 2009 Oct; 23(10):1121-8. PubMed ID: 19404927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-step refolding and purification of recombinant human tumor necrosis factor-α (rhTNF-α) using ion-exchange chromatography.
    Wang Y; Ren W; Gao D; Wang L; Yang Y; Bai Q
    Biomed Chromatogr; 2015 Feb; 29(2):305-11. PubMed ID: 24941919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Simplified Process for Purification and Refolding of Recombinant Human Interferon-α2b.
    Fazeli MR; Hezarjaribi N
    Iran Biomed J; 2022 Jan; 26(1):85-90. PubMed ID: 34861751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of the primary recovery of human interferon alpha2b from Escherichia coli inclusion bodies.
    Valente CA; Monteiro GA; Cabral JM; Fevereiro M; Prazeres DM
    Protein Expr Purif; 2006 Jan; 45(1):226-34. PubMed ID: 16139511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubilization and refolding with simultaneous purification of recombinant human stem cell factor.
    Wang C; Liu J; Wang L; Geng X
    Appl Biochem Biotechnol; 2008 Feb; 144(2):181-9. PubMed ID: 18456949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renaturation with simultaneous purification of rhG-CSF from Escherichia coli by ion exchange chromatography.
    Wang C; Wang L; Geng X
    Biomed Chromatogr; 2007 Dec; 21(12):1291-6. PubMed ID: 17634960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.